Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Kyverna Therapeutics Inc (KYTX)

111 + Investors. Track Smart Money conviction in KYTX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +11
Streak
2Q ▲
Buyers last Q
53%

Smart Money Signals — KYTX

Based on 111 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added KYTX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
111 hedge funds hold KYTX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +28% more funds vs a year ago

fund count last 6Q
+24 new funds entered over the past year (+28% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 53% buying

58 buying51 selling
Last quarter: 58 funds bought or added vs 51 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-11 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 15 → 11 → 37 → 26. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔄

Mostly new holders — 43% entered in last year

■ 22% conviction (2yr+) ■ 35% medium ■ 43% new
Only 24 funds (22%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
🚀

Acceleration phase — new buyers rushing in

16 → 15 → 11 → 37 → 26 new funds/Q
New funds entering each quarter: 15 → 11 → 37 → 26. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
📊

Mixed cohorts — 8% veterans, 40% new entrants

■ 8% veterans ■ 52% 1-2yr ■ 40% new
Of 115 current holders: 9 (8%) held 2+ years, 60 held 1–2 years, 46 (40%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
📋

Smaller funds dominant — 19% AUM from top-100

19% from top-100 AUM funds
30 of 110 holders rank in the top 100 by AUM, but together hold only 19% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
4.7
out of 10
Moderate Exit Risk
Exit risk score 4.7/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — KYTX

In 2026 Q1, 58 hedge funds were net buyers of KYTX (26 opened a new position, 32 added to an existing one), while 51 reduced or exited (36 trimmed, 15 sold completely) — a 53% buyer ratio, indicating a slight buying edge. Net buying has persisted for two consecutive quarters, a positive momentum signal. Net fund flow last quarter: +11 funds (more new holders than closures). Total institutional holders: 111.

Hedge Fund Ownership: KYTX

How many hedge funds hold KYTX — quarterly history vs. share price
Quarterly hedge fund ownership of KYTX vs. share price

Market Analysis: KYTX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: KYTX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Kyverna Therapeutics Inc (KYTX) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much KYTX has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 85d ago
KYTX
-2.3%
XLV
+2.8%

KYTX outperformed XLV by -5.1% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 40d ago
KYTX
-11.2%
XLV
+3.9%

Since the filing became public, KYTX outperformed XLV by -15.1% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

9 top-rated funds 4 high-conviction
Consensus
4.3
/ 10
breadth
×
Elite
3.5
/ 10
conviction
Hedge Fund Positioning: KYTX
111 + Investors

Track Smart Money conviction in KYTX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 111 100 11.0%
13F Shares 35M 34M 1.99%
Total Value $289M $306M -5.63%
New Positions 26 37 -11
Increased Positions 30 30 -
Closed Positions 15 14 +1
Reduced Positions 35 20 +15
Total Calls 4 3 33.33%
Total Puts 1 3 -66.67%
PUT/CALL Ratio 0.25 1.0 Bullish

Statistics: KYTX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

111 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in KYTX. Verified SEC 13F-HR filings.

QUARTER:
Top 25 KYTX holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 GordonMD Global Investments LP 25.51% 4,244,818 $36.6M
2 Caxton Corp 4.03% 18,773 $162K
3 Propel Bio Management, LLC 3.52% 644,421 $5.6M
4 Bain Capital Life Sciences Investors, LLC 2.42% 3,110,000 $26.8M
5 AIGH Capital Management LLC 2.35% 2,000,000 $17.3M
6 Gilead Sciences, INC. 1.68% 4,126,119 $35.6M
7 Mbb Public Markets I LLC 0.63% 614,477 $5.3M
8 Insight Holdings Group, LLC 0.60% 989,054 $8.5M
9 Nano Cap New Millennium Growth Fund L P 0.42% 52,000 $449K
10 Peapod Lane Capital LLC 0.28% 40,404 $336K
11 Deerfield Management Company, L.P. 0.20% 2,000,000 $17.3M
12 Act Capital Management, LLC 0.20% 30,000 $259K
13 Kera Capital Partners, Inc. 0.11% 108,083 $933K
14 Burkehill Global Management, LP 0.09% 200,000 $1.7M
15 Phoenix Wealth Advisors 0.07% 19,800 $171K
16 683 Capital Management, LLC 0.04% 85,000 $734K
17 Diametric Capital, LP 0.04% 16,067 $139K
18 Woodline Partners LP 0.03% 845,325 $7.3M
19 Wesbanco Bank Inc 0.03% 110,300 $952K
20 Bridgeway Capital Management, LLC 0.03% 149,900 $1.3M
21 Simplify Asset Management Inc. 0.02% 173,106 $1.5M
22 Grey Ledge Advisors, LLC 0.02% 10,000 $86K
23 Mangrove Partners IM, LLC 0.02% 27,014 $233K
24 Y-Intercept (Hong Kong) Ltd 0.02% 114,841 $991K
25 Fox Run Management, L.L.C. 0.01% 11,089 $84K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Kyverna Therapeutics Inc (KYTX)

What does the Smart Money Trend signal show for KYTX?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added KYTX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for KYTX?

Slight buying edge — 53% buying: Last quarter: 58 funds bought or added vs 51 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for KYTX holders?

Smaller funds dominant — 19% AUM from top-100: 30 of 110 holders rank in the top 100 by AUM, but together hold only 19% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held KYTX?

Mostly new holders — 43% entered in last year: Only 24 funds (22%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Kyverna Therapeutics Inc (KYTX) following the 2026 Q1 hedge fund 13F filings?

As of today, KYTX has moved -11.2% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.9% for the XLV sector ETF — an outperformance of -15.1%. Since the quarter end (March 31, 2026), KYTX has gained -2.3% vs +2.8% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →